Related Experiment Video
Updated: Jul 9, 2025

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
MicroRNA-93 promotes the pathogenesis of glaucoma by inhibiting matrix metalloproteinases as well as up-regulating
Manhua Xu1, Yanxi Wang1, Juan Zhou1
1Department of Ophthalmology, Nanfang Hospital, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
Objective:
To investigate the effect and potential molecular mechanism of microRNA-93 (miR-93) on retinal ganglion cells (RGCs) apoptosis as well as retinal damage in acute glaucoma mice.
Methods:
RGCs apoptosis were induced by oxygen-glucose deprivation and reperfusion (OGD/R). The pro-apoptotic effect of miR-93 was evaluated by transfecting miR-93 mimics or miR-93 inhibitor into OGD/R-induced RGCs. The viability and apoptosis of RGCs were determined by MTT assay and flow cytometry. Mouse model of acute glaucoma were successfully induced via high intraocular pressure (IOP), and then these model animals were randomly divided into vehicle group, miR-93 mimics group or miR-93 inhibitor group (n = 10), using healthy mice as normal control. Histopathologic changes of retinal tissue were evaluated by Hematoxylin and Eosin (H&E) staining method. Moreover, cell counts of retinal ganglion cell layer and mean thickness of different layers were also determined. Quantitative real-time PCR (qPCR) and western blotting analysis were used to detect the mRNA and protein expression levels of extracellular matrix (ECM), matrix metalloproteinases (MMPs) and Rho/ROCK signaling pathway.
Results:
miR-93 mimics significantly decreased or promoted the viability and apoptosis of OGD/R-induced RGCs, respectively. In addition, miR-93 mimics significantly exacerbated the degree of retinal tissue damage in mice with acute glaucoma, which was accompanied by a decrease in the number of ganglion cell layer (GCL) cells and the thickness of different tissue layers. Moreover, miR-93 mimics significantly increased IOP in mice with acute glaucoma. Significantly, miR-93 inhibitors significantly reversed the above changes. In addition, results of Western blot analysis showed that miR-93 mimics increased and decreased the expression of ECM-associated and MMP-associated proteins, respectively, by activating the Rho/ROCK signaling pathway. In contrast, miR-93 significantly decreased and increased the expression of ECM-associated and MMP-associated proteins, and suppressed the expression of Rho/ROCK signaling pathway-related proteins.
Conclusion:
miR-93 can promote the development of glaucoma by activating Rho/ROCK signaling pathway to mediate the accumulation of ECM-related proteins as well as the down-regulation of MMP-related proteins.
Insights
MicroRNA-93 (miR-93) promotes glaucoma development by activating the Rho/ROCK pathway, leading to retinal ganglion cell apoptosis and damage. Inhibiting miR-93 reverses these effects, offering a potential therapeutic target for glaucoma.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Retinal ganglion cell (RGC) apoptosis is a key pathological feature of glaucoma.
- The role of microRNAs in glaucoma pathogenesis is an emerging area of research.
Purpose of the Study:
- To investigate the effect of microRNA-93 (miR-93) on RGC apoptosis and retinal damage in acute glaucoma.
- To elucidate the molecular mechanism underlying miR-93's action in glaucoma.
Main Methods:
- Oxygen-glucose deprivation and reperfusion (OGD/R) model to induce RGC apoptosis.
- Transfection of miR-93 mimics or inhibitors into RGCs and glaucoma mouse models.
- Assessment of RGC viability, apoptosis, and retinal histopathology.
- Analysis of extracellular matrix (ECM), matrix metalloproteinases (MMPs), and Rho/ROCK signaling pathway expression via qPCR and Western blotting.
Main Results:
- miR-93 mimics promoted RGC apoptosis and exacerbated retinal damage in acute glaucoma models.
- miR-93 mimics increased intraocular pressure (IOP) and altered ECM/MMP protein expression by activating the Rho/ROCK pathway.
- miR-93 inhibitors reversed these detrimental effects.
Conclusions:
- miR-93 plays a pro-glaucoma role by promoting RGC apoptosis and retinal damage.
- The mechanism involves Rho/ROCK pathway activation, leading to ECM accumulation and MMP down-regulation.
- Targeting miR-93 presents a potential therapeutic strategy for glaucoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
MicroRNAs
Role of Matrix Metalloproteases in Degradation of ECM
Glaucoma: Overview
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

